(Q36912872)

17 August 2017

1 reference

title

St. John's wort: role of active compounds for its mechanism of action and efficacy (English)

1 reference

17 August 2017

1

Veronika Butterweck

1 reference

17 August 2017

Mathias Schmidt

2

1 reference

17 August 2017

publication date

1 January 2007

1 reference

Wiener Medizinische Wochenschrift

17 August 2017

published in

1 reference

17 August 2017

volume

157

1 reference

17 August 2017

issue

13-14

1 reference

17 August 2017

page(s)

356-361

1 reference

Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin

17 August 2017

cites work

1 reference

12 December 2020

St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats

1 reference

12 December 2020

Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test

1 reference

12 December 2020

St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature.

1 reference

12 December 2020

Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.

1 reference

12 December 2020

Hyperforin as a possible antidepressant component of hypericum extracts

1 reference

12 December 2020

St John's Wort for depression

1 reference

12 December 2020

Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test

1 reference

12 December 2020

Therapy of depressive states with hypericin

1 reference

12 December 2020

Hyperforin in St. John's wort drug interactions

1 reference

12 December 2020

Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology

1 reference

12 December 2020

St. John's wort and the treatment of mild to moderate depression: a systematic review

1 reference

12 December 2020

Neurochemical studies with St. John's wort in vitro

1 reference

12 December 2020

Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet

1 reference

12 December 2020

Pharmacological activity of hyperforin acetate in rats

1 reference

12 December 2020

Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.

1 reference

12 December 2020

Inhibition of MAO by fractions and constituents of hypericum extract.

1 reference

12 December 2020

In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract

1 reference

12 December 2020

Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity

1 reference

12 December 2020

Efficacy of an Hypericum perforatum (St. John's wort) extract in preventing and reverting a condition of escape deficit in rats

1 reference

12 December 2020

Inhibition of MAO and COMT by hypericum extracts and hypericin.

1 reference

12 December 2020

Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models

1 reference

12 December 2020

Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways

1 reference

12 December 2020

Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex

1 reference

12 December 2020

Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity

1 reference

12 December 2020

Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat

1 reference

12 December 2020

Biochemical mechanisms of action of Hypericum LI 160 in glial and neuronal cells: inhibition of neurotransmitter uptake and stimulation of extracellular signal regulated protein kinase

1 reference

12 December 2020

Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding

1 reference

12 December 2020

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

1 reference

12 December 2020

In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs

1 reference

12 December 2020

Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract

1 reference

12 December 2020

Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort

1 reference

12 December 2020

Mechanism of action of St John's wort in depression : what is known?

1 reference

12 December 2020

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

1 reference

12 December 2020

Modulation of ion channels in rat neurons by the constituents of Hypericum perforatum.

1 reference

12 December 2020

Inhibition of monoamine oxidase by hypericin.

1 reference

12 December 2020

Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment

1 reference

12 December 2020

Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats

1 reference

12 December 2020

Dissolution, solubility and cooperativity of phenolic compounds from Hypericum perforatum L. in aqueous systems.

1 reference

12 December 2020

Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test

1 reference

12 December 2020

Hyperforin modulates gating of P-type Ca2+ current in cerebellar Purkinje neurons

1 reference

12 December 2020

Flavonoids of St. John's Wort reduce HPA axis function in the rat.

1 reference

12 December 2020

1 reference

12 December 2020

Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers

1 reference

12 December 2020

Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility

1 reference

12 December 2020

Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum.

1 reference

12 December 2020

Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort

1 reference

12 December 2020

Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?

1 reference

12 December 2020

In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters

1 reference

12 December 2020

The antidepressant mechanism of Hypericum perforatum.

1 reference

12 December 2020

Phenolic compounds from Hypericum perforatum

1 reference

12 December 2020

Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system

1 reference

12 December 2020

High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro

1 reference

12 December 2020

10.1007/S10354-007-0440-8

Identifiers

DOI

1 reference

17 August 2017

1 reference